Evotec SE Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement2019
Evotec SE (EVO) reported Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement2019 of 1 EUR/shares for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-17.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 · last filed 2025-04-17
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2024-12-31 | 1.00 EUR/shares 20-F · filed 2025-04-17 |
| 2023-12-31 | 1.00 EUR/shares 20-F · filed 2025-04-17 |
| 2022-12-31 | 1.00 EUR/shares 20-F · filed 2024-08-14 |
| 2021-12-31 | 1.00 EUR/shares 20-F · filed 2023-05-12 |
| 2020-12-31 | 1.06 EUR/shares 20-F · filed 2022-04-26 |
| 2019-12-31 | 1.03 EUR/shares 20-F · filed 2022-04-26 |